ATE213742T1 - Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität - Google Patents
Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivitätInfo
- Publication number
- ATE213742T1 ATE213742T1 AT96927035T AT96927035T ATE213742T1 AT E213742 T1 ATE213742 T1 AT E213742T1 AT 96927035 T AT96927035 T AT 96927035T AT 96927035 T AT96927035 T AT 96927035T AT E213742 T1 ATE213742 T1 AT E213742T1
- Authority
- AT
- Austria
- Prior art keywords
- growth hormone
- inhibiting activity
- pct
- somatostatin analogs
- cyclic somatostatin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI001670A IT1277391B1 (it) | 1995-07-28 | 1995-07-28 | Peptidi ciclici analoghi della somatostatina ad attivita' inibitrice dell'ormone della crescita |
| PCT/EP1996/003149 WO1997005167A1 (en) | 1995-07-28 | 1996-07-17 | Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213742T1 true ATE213742T1 (de) | 2002-03-15 |
Family
ID=11372091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96927035T ATE213742T1 (de) | 1995-07-28 | 1996-07-17 | Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5962409A (de) |
| EP (1) | EP0842193B1 (de) |
| JP (1) | JPH11510147A (de) |
| KR (1) | KR100321448B1 (de) |
| AT (1) | ATE213742T1 (de) |
| AU (1) | AU6700996A (de) |
| BR (1) | BR9609801A (de) |
| CA (1) | CA2227980A1 (de) |
| DE (1) | DE69619530T2 (de) |
| DK (1) | DK0842193T3 (de) |
| ES (1) | ES2171704T3 (de) |
| IT (1) | IT1277391B1 (de) |
| PT (1) | PT842193E (de) |
| WO (1) | WO1997005167A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6579967B1 (en) | 1999-12-14 | 2003-06-17 | The Salk Institute For Biological Studies | Receptor-selective somatostatin analogs |
| GB0018891D0 (en) | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
| US7019109B2 (en) * | 2001-03-16 | 2006-03-28 | The Salk Institute For Bilogical Studies | SSTR1-selective analogs |
| US20040121407A1 (en) * | 2002-09-06 | 2004-06-24 | Elixir Pharmaceuticals, Inc. | Regulation of the growth hormone/IGF-1 axis |
| CN1317031C (zh) * | 2005-09-14 | 2007-05-23 | 上海第二医科大学附属新华医院 | 增强实体肿瘤细胞化疗敏感性的高效混合制剂 |
| EP2275103B1 (de) | 2005-11-21 | 2014-04-23 | Novartis AG | mTOR-Inhibitoren in der Behandlung endokriner Tumore |
| JP6211418B2 (ja) * | 2011-09-04 | 2017-10-11 | 株式会社糖鎖工学研究所 | 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725577A (en) * | 1985-04-25 | 1988-02-16 | Administrators Of The Tulane Educational Fund | Biologically active lysine containing octapeptides |
| US4904642A (en) * | 1985-09-12 | 1990-02-27 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
| GR862206B (en) * | 1985-09-12 | 1986-12-31 | Univ Tulane | Therapeutic somatostatin analogs |
| IT1240643B (it) * | 1990-05-11 | 1993-12-17 | Mediolanum Farmaceutici Spa | Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano |
| HU207104B (en) * | 1991-01-25 | 1993-03-01 | Biosignal Kutato Fejlesztoe Kf | Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds |
| AU657770B2 (en) * | 1991-06-03 | 1995-03-23 | Mallinckrodt Medical, Inc. | Radiolabelled somatostatin derivatives, their preparation and use |
| WO1992021283A1 (en) * | 1991-06-06 | 1992-12-10 | Somanetics Corporation | Optical cerebral oximeter |
-
1995
- 1995-07-28 IT IT95MI001670A patent/IT1277391B1/it active IP Right Grant
-
1996
- 1996-07-17 BR BR9609801A patent/BR9609801A/pt not_active IP Right Cessation
- 1996-07-17 AT AT96927035T patent/ATE213742T1/de not_active IP Right Cessation
- 1996-07-17 EP EP96927035A patent/EP0842193B1/de not_active Expired - Lifetime
- 1996-07-17 AU AU67009/96A patent/AU6700996A/en not_active Abandoned
- 1996-07-17 WO PCT/EP1996/003149 patent/WO1997005167A1/en not_active Ceased
- 1996-07-17 DE DE69619530T patent/DE69619530T2/de not_active Expired - Fee Related
- 1996-07-17 ES ES96927035T patent/ES2171704T3/es not_active Expired - Lifetime
- 1996-07-17 PT PT96927035T patent/PT842193E/pt unknown
- 1996-07-17 US US08/983,363 patent/US5962409A/en not_active Expired - Fee Related
- 1996-07-17 KR KR1019980700622A patent/KR100321448B1/ko not_active Expired - Fee Related
- 1996-07-17 JP JP9507186A patent/JPH11510147A/ja not_active Ceased
- 1996-07-17 CA CA002227980A patent/CA2227980A1/en not_active Abandoned
- 1996-07-17 DK DK96927035T patent/DK0842193T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2171704T3 (es) | 2002-09-16 |
| AU6700996A (en) | 1997-02-26 |
| ITMI951670A1 (it) | 1997-01-28 |
| DK0842193T3 (da) | 2002-04-29 |
| EP0842193B1 (de) | 2002-02-27 |
| IT1277391B1 (it) | 1997-11-10 |
| KR100321448B1 (ko) | 2002-07-31 |
| US5962409A (en) | 1999-10-05 |
| KR19990035961A (ko) | 1999-05-25 |
| ITMI951670A0 (it) | 1995-07-28 |
| BR9609801A (pt) | 1999-07-06 |
| CA2227980A1 (en) | 1997-02-13 |
| EP0842193A1 (de) | 1998-05-20 |
| PT842193E (pt) | 2002-06-28 |
| HK1008225A1 (en) | 1999-05-07 |
| JPH11510147A (ja) | 1999-09-07 |
| DE69619530T2 (de) | 2002-08-08 |
| WO1997005167A1 (en) | 1997-02-13 |
| DE69619530D1 (de) | 2002-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| DE69401204D1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
| NO962664D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
| BR9611175B1 (pt) | compostos e composiÇÕes farmacÊuticas. | |
| DE69326250D1 (de) | Neuropeptide y antagoniste | |
| ATE364079T1 (de) | Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung | |
| PT1149910E (pt) | Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus | |
| SE9101838D0 (sv) | Novel peptides and their use | |
| FI973221A0 (fi) | 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina | |
| ATE165827T1 (de) | Herstellung von n-acetylneuraminsäure-derivaten | |
| DE68902192D1 (de) | Ethylenthioharnstoff enthaltende zusammensetzungen zur herstellung von verschleissfesten, stromlos abgeschiedenen nickel-borueberzuegen. | |
| DE69619530D1 (de) | Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität | |
| ATE110742T1 (de) | Peptid-verbindungen. | |
| IL122606A0 (en) | (S)-hydroxy-nitrile-lyase | |
| DE3765808D1 (de) | Heterocyclische tetrahydro-3,4-diamin-n-n'-platin-komplexe. | |
| ATE385805T1 (de) | Neue peptide | |
| ES2173586T3 (es) | Derivados de ciclohexandiol. | |
| ATE247088T1 (de) | Peptidverbindungen mit mmp- und tnf-hemmender wirkung | |
| AU6722498A (en) | Disubstituted biphenyloxazolines | |
| ES2109373T3 (es) | Nueva proteina inhibidora de trombina a partir de garrapatas. | |
| MX9802268A (es) | Nuevos derivados de la substancia pf1022 de ciclodepsipeptido. | |
| BR9915130A (pt) | Antagonistas de receptor de crf e processos relacionados aos mesmos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |